Introduction: Primary open angle glaucoma (POAG) is a progressive optic neuropathy characterized by impaired aqueous outflow and extensive remodeling in the trabecular meshwork (TM). The aim of this study was to characterize and compare the expression patterns of selected proteins belonging to the tissue remodeling, inflammation and growth factor pathways in ex vivo glaucomatous and post-mortem TMs using protein-array analysis. Methods: TM specimens were collected from 63 white subjects, including 40 patients with glaucoma and 23 controls. Forty POAG TMs were collected at the time of surgery and 23 post-mortem specimens were from non-glaucomatous donor sclerocorneal tissues. Protein profiles were evaluated using a chip-based array consisting of 60 literature-selected antibodies.
INTRODUCTION
Primary open angle glaucoma (POAG), the most common form of glaucoma, is a multifactorial disease with unclear pathogenesis, characterized by retinal ganglion cell death and irreversible damage of the optic nerve [1, 2] . Elevated intraocular pressure (IOP) represents the main risk factor involved in the onset and progression of POAG, due to an imbalance between aqueous humor production and outflow [3, 4] . POAG trabecular meshwork (TM) displays chronic inflammation and long-standing tissue remodeling [5, 6] . These molecular events are mainly of endogenous origin and related to the long-term accumulation of oxidative damages arising from mitochondrial failure and endothelial dysfunction [7] . Proteins deriving from the damage occurring in endothelial TM cells underwent dramatic variation, reflecting oxidative damage, mitochondrial damage, neural degeneration, and apoptosis [8, 9] .
Structural changes encompass extensive extracellular matrix (ECM) deposition, typified by increased collagen, fibronectin and elastin deposition (thickness of trabecular sheets), impaired growth factors release, unbalance in ECM enzymes and unusual myofibroblast development [10] [11] [12] [13] [14] [15] . Apoptosis of endothelial cells and targets of oxidative stress (glyceraldehyde-3-phosphate dehydrogenase [GAPDH], a glycolytic enzyme; heat shock 70 kDa protein 1 [HSP72], a stress protein; and glutamine synthetase, an excitotoxicity-related protein) were detected in POAG TMs, supporting the presence of a continuous inflammation, remodeling and immune system activation [16, 17] . While many components of TM ECM have been identified, only few studies address the entire TM proteome. Cumulating data point to impaired synthesis/release of transforming growth factor beta (TGFbs), nerve growth factor (NGF), vascular endothelial growth factor (VEGF), connective tissue growth factor (CTGF), tumor necrosis factor alpha (TNFa), interleukin (IL)1a, IL2, IL8, fibroblast growth factor (FGF), and their receptors, detected by single conventional approaches [18] [19] [20] [21] [22] . Some pro-inflammatory/fibrogenic factors have been detected in the aqueous humor, suggestive of future applications [23] [24] [25] .
To date, the mechanism and the molecular basis responsible for structural, biochemical, and functional changes occurring in glaucomatous TM are poorly understood [26, 27] . Several studies have been performed to identify systemic and local biochemical risk factors and some novel protein/antibody profiles have been prospected as potential targets to counteract the degenerative effects in POAG, in addition to the IOP [3, 4, 28] .
Recently, the protein microarray approach has highlighted, most resourceful than conventional approach, some candidates (biomarkers) for POAG, pertinent to routine diagnostic applications/monitoring of treatment efficacy or to target therapy [18, 29, 30] .
The aim of the present study was to explore the expression of some factors in TMs from patients with POAG.
METHODS

Ethics Statement
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national), with the Helsinki Declaration of 1964, as revised in 2013, and was reviewed/approved by the institutional Ethic Committee (IRCCS IFO-Fondazione Bietti). A written informed consent was signed by patients joining the study and undergoing surgical therapy.
POAG Population
A total of 40 POAG and 23 age/sex-matched post-mortem TM specimens were used for the study ( [31] .
Chip-Based Arrays for Proteome Analysis
The proteome array was performed on extracts were processed in parallel. After an overnight incubation at 4°C, the array slides were washed and exposed to a biotinylated antibody mixture followed by a cy3-streptAvidin labeling solution. All steps were performed under orbital shaking (CertomaxII, Sartorius AG) and all the hybridization/washing solutions were provided by the kit. As a final point, the glass-slides were washed once with MilliQ water, spin-dried and acquired with a GenePix 4400 Microarray scanner (Molecular Devices LLC, Sunnyvale, Silicon Valley, CA). To obtain appropriate Cy5 (background signal) and Cy3 (specific signal) images, the slides were scanned over previously validated acquisition parameters and the images/arrays (blocks) were uniformly adjusted for size, brightness and contrast at the moment of acquisition. Using the SPOT tool, the specific area (corresponding to each cytokine on the array) was manually spotted and automatically adjusted, according to prefixed acquisition parameters applied to all glass-slides of the study. The fluorescent intensity data (FI) of each spot was calculated by the GenePix Pro 6.0 pro software (Molecular Devices), that provide background-subtracted FI data (F532-B532, N factor) as of a value for spot volume representing the product of the area and the highest pixel value contained in that area.
Confirmation Experiments by Western
Blot, Zymography, and Real-Time PCR
Western Blotting
The membranes from electrophoretic analysis were equilibrated in 0.5% Triton, blocked in 3% BSA, incubated with the primary antibodies (0.2-0.8 lg/mL, 18 h; MMP2 (sc-10736) and MMP7 (sc-130819) were from Santa Cruz; TGFb1 (mab240) and VEGF (AF-293-NA) were purchased from R&D Systems, Minneapolis, Il) and labeled with secondary specie-specific POD-conjugated antibodies (1/7000, 90 min; Jackson Laboratories, West Grove, PA). The specific signals were visualized by SuperSignal West Pico Trial (Pierce).
Zymography
To study MMP2 and MMP9 functional activity, tissue extract were three fold-concentrated 
Statistical Analysis
POAG and post-mortem TMs were analyzed in duplicate (spots/bands) and mean values (±SD) were calculated from these replicates. Individual biomarker expression was provided by GenePix software. The row spot intensity data were entered into a Microsoft Excel database (Microsoft, Redmond, WA) and duplicate spots outside the 10% coefficient of variability were refused from the statistical analysis. FDR value of 0.01, as observed. Protein response ratios were defined as the variation in a given marker and a cut-off of two fold (changes) was used for differential expression, in accordance with previously published methods [32, 33] shown in Fig. 1a . The total protein amount was detectable in all specimens included in the study, and representative spectrophotometer plots are shown in Fig. 1b . The electrophoretic analysis of POAG TM revealed the presence of To facilitate the reading/analysis of chip-array grids in Fig. 2a , appropriate clusters were defined. Two representative cy3-labeled fluorescence subarrays are reported in Fig. 2b, c 
DISCUSSION
POAG represents one of the major leading causes of blindness worldwide, with poor early diagnosis and prognosis [1, 2, 28, 34] . Currently, no therapy is curative and an early diagnosis and/or a prompt intervention in ''risk patients'' would contribute significantly to reduce the progression of disease [1, 2, 24] . [17, 35] . Several genes/proteins (soluble and stress-related mediators, growth factors, cytoskeletal and ECM-associated proteins) have been identified in POAG (mainly in TM-derived cells, aqueous humors, tears and blood) and proposed as potential candidates for the prognosis of disease and monitoring of therapy [24, 36] .
Since any effort in the characterization of POAG-associated protein profile will be of great importance in understanding the mechanisms underlying POAG progression, a nonbiased chip-based microarray approach was carried out to discriminate 60 antibodies for potential proteins/factors relevant to pathological TM.
The selected potential candidates are all known to be involved in chronic inflammation and tissue remodeling [16, 24, 28, 31, [36] [37] [38] [39] .
To the best our knowledge in literature, this
is the first study conducted in vivo on human normal and glaucomatous TMs. From this comparative analysis, 32 out of 60 explored candidates were significantly affected in POAG specimens, as compared to control specimens dissected out from non-glaucomatous [17, 24, 35, 40] .
During glaucoma, macrophages produce cytokines including IL6, IL1b and TNFa, leading to an acute inflammatory response.
These cytokines can induce ECM remodeling and alter cytoskeletal interactions in the glaucomatous TM [20] . The increased expression of IL6 and IL10 in glaucomatous TMs is in line with the increased IL10 and IL6 levels detected, respectively, in glaucomatous fluids (sera and aqueous) and strongly support the hypothesis of IL10 and IL6 as potential biomarkers of prognosis of disease or therapy [25, [40] [41] [42] [43] . The high expression of IL6 might be explained with the remodeling process occurring in glaucomatous TMs and the IL6-TGFb1 cross talk observed in TM-derived primary cultures [40, 43, 44] . IL6 increased outflow facility in perfused anterior segments of porcine eyes and IL6 levels were increased in porcine TM cells as a result of oxidative challenge [45, 46] . Besides, IL6 and IL8 have been implicated in induction of cellular senescence [47] . TNFa and IL6 mediate human microvascular endothelial tight junction modulation, by their ability of cytoskeletal rearrangment [48] . Finally, IL8 was found to modulate the permeability of the Schlemm's canal endothelial cells [49] .
On the other hand, the increase of IL7 might be explained with the IL7 ability to counteract the TGFb 1 activity, as observed in other in vitro models [50] . By contrary, the high IL10 expression is actually missing of explanation, although in experimental models of fibrosis the IL10 triggered (i) the anti-inflammatory response through the inhibition of TNFa, IL1, IL6, IL8, IL12, MIP1a and MIP2a release from monocytes/macrophages (anti-inflammatory response), (ii) the macrophage activity (down-regulating response MMPs/TGFb 1 ) and
(iii) the up-regulation of TIMPs [43, 51] . Of interest, the significant increase of MIP1a/ d and decrease of MIP1b as well as the increase of VCAM1 and decrease of ICAM3 might support the presence of an anti-inflammatory response, as observed in other systems [52] . As for IL10, the increase of MIPs might be involved in the modulation of macrophage migration, the activation of granulocytes and the modulation of IL5, IL3, IL4 and IL12 inflammatory/profibrogenic activity [52] . The high sTNFRI expression might represent a point of interest, since it has been recently reported that this soluble receptor might be involved in the regulation of TNFa receptor activity [53] .
With respect to the significant low expression of IL18 and IL16 actually we have no explanation.
The observation of the overexpression of IgG bands in the electrophoretic profiles might suggest the contribution of B cell implying potential neuroprotective effects, as previously described [31, 54, 55] . [59] . Therefore, although it is not possible (in this study) to eliminate the influences and interference of therapy, the proteins found reflect the real profile of glaucomatous proteome.
Altogether the protein chip-based array indicates some new factors (IL7, MIPs, sTNFaRI) and confirm some old ones (IL10, IL6, IL5, IL12, VEGF, TGFb 1 and NGF), all indicative of an active inflammatory process, as previously described [60, 61] . Indeed, both protein and mRNA evaluations highlight the presence of an active process of tissue remodeling and angiogenesis (MMP2, MMP7, VEGF, TGFb 1 ). Current studies are underway to correlate this glaucomatous TM expression with those of some glaucomatous body fluids (aqueous, tears and blood). 
